This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
The San Diego site is one of PCI’s eight global Clinical locations across the US, EU and Asia Pacific regions – supporting Clinical Trials in more than 100 countries around the world.
PCI’s new two-story 38,000 sq ft state of the art facility – located less than a mile from its existing San Diego campus – will serve as PCI’s main storage, logistics and distribution center on the West Coast. Beyond controlled room temperature, the building will be equipped for Cold Chain requirements for 2-8°C, -20°C, and -80°C with expanded ultra-low freezer capabilities, as well as cryogenic liquid nitrogen storage at -196°C.
The site expansion project will be completed and validated during the fourth quarter of 2019.
PCI’s Mark Shepanski, Executive Director of Operations and Site Lead for San Diego, said: “Securing our third site in San Diego allows us to continue to provide industry-leading reliability, flexibility and quality in clinical supply management services.
“We began to investigate our requirements for the additional facility last year, anticipating our customers would eventually need additional storage space for their larger Clinical studies. As our customers experience continued success, we want to make sure we adapt and grow with them.”
This announcement is the latest reflecting PCI’s commitment to the continued development and expansion of its global clinical supply network in anticipation of future customer needs; a strategy which includes ongoing and considerable capital investment in facilities and increased capacity.
To find out more, please visit here.
